APC Anti-CD45.1 antibody [A20]
Be the first to review this product! Submit a review
|
(3 Publications)
Mouse Monoclonal CD45 antibody - conjugated to APC. Suitable for Flow Cyt and reacts with Mouse samples. Cited in 3 publications.
View Alternative Names
CD45, Ly-5, Ptprc, Receptor-type tyrosine-protein phosphatase C, Leukocyte common antigen, Lymphocyte antigen 5, T200, L-CA
- Flow Cyt
Supplier Data
Flow Cytometry - APC Anti-CD45.1 antibody [A20] (AB25348)
Flow Cytometry analysis of C57Bl/6 (left panel) or SJL (right panel) splenocytes labeling CD45.1 with ab25348 at 0.5 μg (solid line) or Mouse IgG2a (Allophycocyanin) isotype control at 0.5 μg (dashed line).
Related conjugates and formulations (6)
-
Anti-CD45.1 antibody [A20]
-
Cy5 ® Anti-CD45.1 antibody [A20]
-
519 FITC
FITC Anti-CD45.1 antibody [A20]
-
Biotin Anti-CD45.1 antibody [A20]
-
667 PE/Cy5®
PE/Cy5® Anti-CD45.1 antibody [A20]
-
695 PerCP/Cy5.5®
PerCP/Cy5.5® Anti-CD45.1 antibody [A20]
Reactivity data
You may be interested in:
Why is this recommended?
We recommend this product because it’s often used in the same experiment or related research.
We advise that you always check the datasheet to ensure it fits your experiments, or contact ourtechnical teamfor help.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CD45.1 influences the immune response by modulating signals through antigen receptors. It operates as a single-pass type I membrane protein and is not known to be part of a larger complex. This protein is important in the activation and regulation of T-cells and B-cells by fine-tuning the threshold of signals required for cell activation. The presence of CD45.1 affects multiple processes in adaptive immunity impacting lymphocyte development and their further activation in immune responses.
Pathways
CD45.1 is integral in lymphocyte activation pathways. It influences the T-cell receptor (TCR) and B-cell receptor (BCR) signaling pathways by dephosphorylating specific kinases like Lck and Fyn which are important in initiating TCR and BCR signaling cascades. Moreover CD45.1 interacts with other proteins such as CD3 and CD19 being essential in the regulation of immune response and maintaining proper signaling amplitudes to ensure effective immune function.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
JCI insight 8: PubMed36394951
2023
Applications
Unspecified application
Species
Unspecified reactive species
Blood 87:4049-56 PubMed8639760
1996
Applications
Unspecified application
Species
Unspecified reactive species
Transplantation 57:249-56 PubMed7906058
1994
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Associated Products
Alternative Version
Primary Antibodies
AB24982
Cy5 ® Anti-CD45.1 antibody [A20]
primary-antibodies
cy5-cd451-antibody-a20-ab24982
0
(0 reviews)
Alternative Version
Primary Antibodies
AB24917
FITC Anti-CD45.1 antibody [A20]
primary-antibodies
fitc-cd451-antibody-a20-ab24917
4
(1 reviews)
Alternative Version
Primary Antibodies
AB25011
Biotin Anti-CD45.1 antibody [A20]
primary-antibodies
biotin-cd451-antibody-a20-ab25011
0
(0 reviews)
Alternative Version
Primary Antibodies
AB25349
PE/Cy5® Anti-CD45.1 antibody [A20]
primary-antibodies
pe-cy5-cd451-antibody-a20-ab25349
0
(0 reviews)
Alternative Version
Primary Antibodies
AB210237
PerCP/Cy5.5® Anti-CD45.1 antibody [A20]
primary-antibodies
percp-cy55-cd451-antibody-a20-ab210237
0
(0 reviews)
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com